Literature DB >> 6795138

Waldenstrom's macroglobulinemia, a hyperviscosity manifestation of venous stasis retinopathy.

S S Feman, R S Stein.   

Abstract

Waldenstrom's macroglobulinemia is characterized by hyperviscosity. This is usually the result of an increased serum concentration of IgM molecules; this paraprotein has a high molecular weight and unusual shape. The changes in shear rate associated with increased IgM concentrations produces maximal viscosity in the venous circulation. One of the major causes of retinal venous occlusion is venous stasis retinopathy. The typical patient with this disorder is a young individual with a periphlebitis.. However, the hyperviscosity in Waldenstrom's macroglobulinemia is an ideal representative of a venous stasis that is without associated vascular pathology. To illustrate this situation, two cases are described and their etiologic features are discussed.

Entities:  

Mesh:

Year:  1981        PMID: 6795138     DOI: 10.1007/BF00139584

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  22 in total

1.  RETINAL FINDINGS ASSOCIATED WITH SERUM HYPERVISCOSITY.

Authors:  R E CARR; P HENKIND
Journal:  Am J Ophthalmol       Date:  1963-07       Impact factor: 5.258

2.  Reversal of retinopathy in Waldenstrom's macroglobulinemia by plasmapheresis. A report of two cases.

Authors:  P J SCHWAB; E OKUN; J L FAHEY
Journal:  Arch Ophthalmol       Date:  1960-10

3.  Experimental central retinal vein occlusion. A comparison of intraocular and extraocular occlusion.

Authors:  T Fujino; V T Curtin; E W Norton
Journal:  Arch Ophthalmol       Date:  1969-03

4.  Arterial insufficiency in retinal venous occlusion (a short symposium).

Authors:  A Paton; K Rubinstein; V H Smith
Journal:  Trans Ophthalmol Soc U K       Date:  1964

5.  Hyperviscosity retinopathy. A scientific approach to therapy.

Authors:  C F Grindle; N A Buskard; D L Newman
Journal:  Trans Ophthalmol Soc U K       Date:  1976-07

6.  Immunofluorescent studies of the eye in Waldenström's macroglobulinemia.

Authors:  A H Freidman; A Marchevsky; J G Odel; M A Gerber; S N Thung
Journal:  Arch Ophthalmol       Date:  1980-04

7.  Surface bound immunoglobulins as a cell marker in human lymphoproliferative diseases.

Authors:  J L Preud'homme; M Seligmann
Journal:  Blood       Date:  1972-12       Impact factor: 22.113

8.  So-called "central retinal vein occlusion". I. Pathogenesis, terminology, clinical features.

Authors:  S S Hayreh
Journal:  Ophthalmologica       Date:  1976       Impact factor: 3.250

9.  Blood viscosity in Waldenström macroglobulinemia.

Authors:  M R MacKenzie; T K Lee
Journal:  Blood       Date:  1977-04       Impact factor: 22.113

10.  Clinical and pathologic features of Waldenström's macroglobulinemia in seven patients with serum monoclonal IgG or IgA.

Authors:  T Tursz; J C Brouet; G Flandrin; F Danon; J P Clauvel; M Seligmann
Journal:  Am J Med       Date:  1977-10       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.